As of Oct 17
| +1.13 / +1.24%|
The 16 analysts offering 12-month price forecasts for AbbVie have a median target of 94.50, with a high estimate of 107.00 and a low estimate of 60.00. The median estimate represents a +2.53% increase from the last price of 92.17.
The current consensus among 20 polled investment analysts is to Hold stock in AbbVie. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.